GSK’s Gepotidacin Oral Antibiotic Non-Inferior To Commonly Used Muscle-Injected Antibiotic Combo For Sexually Transmitted Infection – GSK (NYSE:GSK)
GSK’s Breakthrough Oral Antibiotic Gepotidacin in the Fight Against STIs The Rise of GSK’s Gepotidacin: A Game-Changer in STI Treatment On Monday, GSK plc unveiled headline results from the EAGLE-1 phase 3 trial for gepotidacin, a groundbreaking oral antibiotic designed for the treatment of uncomplicated …